Vanodiwa vatengi
Sezvo denda reSARS-CoV-2 richifambira mberi, shanduko nyowani uye akasiyana ehutachiona anoramba achibuda, izvo zvisiri atypical. Parizvino, tarisiro iri pamusiyano kubva kuEngland neSouth Africa ine mukana wekuwedzera hutachiona, uye mubvunzo ndewekutikukurumidza antigen miedzoinogona zvakare kuona shanduko iyi.
Sekuferefeta kwedu, akati wandei saiti shanduko dzakaitika dze spike protein panzvimbo dzeN501Y, E484K, K417N yeSA mutant strain 501Y.V2, uye yeN501Y, P681H, 69-70 yeUK mutant strain b.1.1.7 (Kubva kubva Guangdong Provincial Center for Disease Control and Prevention). Sezvo nzvimbo inocherechedzwa yezvinhu zvakapfava zvinoshandiswa muyedzo yedu yeantigen ndiyo nucleocapsid protein yakasiyana nenzvimbo dzekuchinja, Iri puroteni riri pamusoro pehutachiona uye rinodiwa kuti hutachiona hupinde musero rinogamuchira.
Nekudaro, iyo Testsealabs COVID-19 Antigen Rapid Test inoedza imwe puroteni yehutachiona, inonzi nucleocapsid protein, iri mukati mehutachiona uye haina kuchinjwa nekuchinja. Nekudaro, zvinoenderana nemamiriro azvino esainzi, musiyano uyu unogona zvakare kuwonekwa neTestsealabs COVID-19 Antigen Rapid Test.
Zvichakadaro, isu tichakurumidza kutaura chero zvigadziriso zvine chekuita neSARS-CoV-2Antigen Rapid Test Kit. Mukuwedzera, isu tichaenderera mberi nekuedza kwedu kutevedzera zvakakwiriraHunhu hwekutarisira mwero uye kuchengetedza inowirirana yemhando yepamusoro manejimendi system kuti ive nechokwadi chekugutsikana kwevatengi uye kuchengetedzwa kwechigadzirwa. Kana uine mibvunzo, tapota taura nemumiririri wedu wekutengesa.
Hangzhou Testsea Biotechnology Co., Ltd
Nguva yekutumira: Jan-21-2021